Systemic treatment of AIDS-related Kaposi sarcoma: Current status and perspectives

Kaposi’s sarcoma (KS) is the most frequent type of cancer in patients with Acquired Immune Deficiency Syndrome (AIDS). In the western world, its incidence decreased dramatically in the era of highly active anti-retroviral therapy (HAART). In contrast, the incidence of KS has been steadily climbing i...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer treatment reviews Ročník 32; číslo 6; s. 445 - 455
Hlavní autori:	Vanni, Tazio, Sprinz, Eduardo, Machado, Marcelo Warlet, Santana, Rodrigo de C., Fonseca, Benedito Antonio L., Schwartsmann, Gilberto
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier Ltd 01.10.2006
Predmet:	Acquired Immunodeficiency Syndrome - complications Acquired Immunodeficiency Syndrome - drug therapy Adult AIDS Anthracyclines - administration & dosage Antineoplastic Combined Chemotherapy Protocols Antiretroviral Therapy, Highly Active Antiviral Agents - therapeutic use Clinical Trials as Topic Human immunodeficiency virus Humans Interferons - therapeutic use Kaposi’s Sarcoma Liposomes Male Paclitaxel - administration & dosage Sarcoma, Kaposi - drug therapy Sarcoma, Kaposi - epidemiology Sarcoma, Kaposi - virology Treatment Kaposi’s Sarcoma AIDS Treatment
ISSN:	0305-7372, 1532-1967
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!